Stay updated on Cabometyx + Avelumab in mRCC Clinical Trial
Sign up to get notified when there's something new on the Cabometyx + Avelumab in mRCC Clinical Trial page.

Latest updates to the Cabometyx + Avelumab in mRCC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays a 403 Forbidden error with the standard header and footer, indicating access to the study record is blocked. This reflects a permission/availability issue rather than an update to substantive study content.SummaryDifference18%

- Check36 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6. This reflects a minor version update in the documentation system and does not alter visible content.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision: v3.6.5 was added. A large set of core terms including drug names and disease terms were removed from the study record's indexing fields, altering how the trial is described and surfaced in searches.SummaryDifference17%

- Check72 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4, representing a small internal update to the page's version metadata without altering visible content.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page footer now shows Revision: v3.6.3, replacing the previous v3.6.2. This indicates a site version update and does not modify the study details or how the page functions.SummaryDifference0.1%

- Check100 days agoChange DetectedRevision label changed from v3.6.0 to v3.6.2, reflecting a software release update for the site.SummaryDifference0.1%

Stay in the know with updates to Cabometyx + Avelumab in mRCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabometyx + Avelumab in mRCC Clinical Trial page.